Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above 200 Day Moving Average of $0.00

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.88. Xtant Medical shares last traded at $0.84, with a volume of 74,084 shares changing hands.

Xtant Medical Price Performance

The company has a current ratio of 2.82, a quick ratio of 1.22 and a debt-to-equity ratio of 0.34.

Institutional Trading of Xtant Medical

A number of large investors have recently modified their holdings of XTNT. Vanguard Group Inc. increased its holdings in Xtant Medical by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 1,499,993 shares of the medical device company’s stock valued at $1,695,000 after buying an additional 14,653 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in Xtant Medical by 156.7% in the fourth quarter. Goldman Sachs Group Inc. now owns 33,176 shares of the medical device company’s stock valued at $37,000 after buying an additional 20,253 shares during the last quarter. Bridgeway Capital Management LLC increased its holdings in Xtant Medical by 118.7% in the fourth quarter. Bridgeway Capital Management LLC now owns 368,500 shares of the medical device company’s stock valued at $416,000 after buying an additional 200,000 shares during the last quarter. Citadel Advisors LLC increased its holdings in Xtant Medical by 88.5% in the fourth quarter. Citadel Advisors LLC now owns 59,866 shares of the medical device company’s stock valued at $68,000 after buying an additional 28,105 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in Xtant Medical by 38.3% in the fourth quarter. Northern Trust Corp now owns 58,666 shares of the medical device company’s stock valued at $66,000 after buying an additional 16,257 shares during the last quarter. Hedge funds and other institutional investors own 69.33% of the company’s stock.

Xtant Medical Company Profile

Xtant Medical Holdings, Inc develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix.